Clinical Trials Logo

Filter by:
NCT ID: NCT00121784 Terminated - Clinical trials for Heart Transplantation

Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients

Start date: October 2005
Phase: Phase 4
Study type: Interventional

Heart transplant patients on a standard care regimen of CNI, MMF, and corticosteroids will enter the study 4-6 weeks post-transplant. At 3 months after transplant, patients will be randomized to either continue this regimen or CNI therapy will be discontinued and replaced by sirolimus therapy (in combination with MMF and corticosteroids). The effect of these 2 regimens on efficacy, safety and renal function will be evaluated.The anticipated time on study treatment is 1-2 years and the target sample size is 500+ individuals.

NCT ID: NCT00120380 Terminated - Hypertension Clinical Trials

Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)

Start date: September 2004
Phase: Phase 4
Study type: Interventional

The purpose of this study is to test whether the addition of inhaled iloprost is safe and effective in patients with idiopathic pulmonary arterial hypertension who are already being treated with the endothelin receptor antagonist bosentan.

NCT ID: NCT00118573 Terminated - Clinical trials for Aortic Aneurysm, Abdominal

Comparison of Surveillance Versus Aortic Endografting for Small Aneurysm Repair

CAESAR
Start date: September 2004
Phase: Phase 4
Study type: Interventional

Objective of the present study is to compare endovascular repair versus surveillance and, eventually delay treatment in patients with small abdominal aortic aneurysms (AAA), with respect to patient survival, AAA rupture and AAA related death risks.

NCT ID: NCT00117702 Terminated - Clinical trials for Graft vs Host Disease

Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus

Start date: October 2005
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this pilot study is to provide preliminary data about the efficacy and the safety of the combination of tacrolimus with everolimus in the prophylaxis of the graft-versus-host-disease (GvHD) in patients after allogeneic stem cell transplantation.

NCT ID: NCT00107081 Terminated - Cancer Clinical Trials

Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting

Start date: January 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether, in children with cancer presenting with fever in severe chemotherapy-induced neutropenia at low risk for medical complications, oral antibiotics in an outpatient setting after an initial phase of intravenous antibiotics and in-hospital observation for 8 to 22 hours, is not inferior as to safety and efficacy compared to continued intravenous antibiotics given in-hospital.

NCT ID: NCT00104936 Terminated - Clinical trials for Brain and Central Nervous System Tumors

Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Meningioma That Has Been Partially Removed by Surgery

Start date: December 2004
Phase: Phase 3
Study type: Interventional

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue. Giving radiation therapy or radiosurgery after surgery may kill any remaining tumor cells. It is not yet known whether radiation therapy or radiosurgery is more effective than observation alone in treating benign meningioma. PURPOSE: This randomized phase III trial is studying radiation therapy or radiosurgery to see how well they work compared to observation alone in treating patients with newly diagnosed, benign meningioma that has been partially removed by surgery.

NCT ID: NCT00104429 Terminated - HIV Infection Clinical Trials

GW873140 In Combination With Combivir In HIV Infected Subjects

Start date: January 2005
Phase: Phase 2
Study type: Interventional

This study is a 96-week study designed to evaluate the safety and efficacy of GW873140 in combination with Combivir in HIV infected, untreated subjects.

NCT ID: NCT00102778 Terminated - HIV Infection Clinical Trials

GW873140 In Combination With Kaletra In HIV Infected Subjects

Start date: December 2004
Phase: Phase 2
Study type: Interventional

This study is a 96-week study designed to evaluate the safety and efficacy of GW873140 in combination with Kaletra in HIV infected, untreated subjects.

NCT ID: NCT00102284 Terminated - Healthy Clinical Trials

Neuromodulation and Language Acquisition (Project Stage Ia)

Start date: March 2004
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether levodopa, pergolid, rivastigmine, or modafinil are effective in boosting semantic language acquisition in healthy subjects.

NCT ID: NCT00102128 Terminated - Clinical trials for Ischemic Heart Disease

Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.

Start date: November 2002
Phase: Phase 2
Study type: Interventional

Study to examine the safety and effectiveness of implanted skeletal muscle cells (cells removed from the thigh muscle) into scarred areas of heart muscle after heart attack.